In a population from Burkina Faso, KIR2DL2, KIR2DL3, and KIR2DS2 are associated with chronic stages of HBV infection, while KIR3DL1, KIR3DL2, KIR2DS1, and KIR2DP1 are associated with immunity against the infection [260]. This evidence concerns the gene KIR2DL3 and infection.